"Best of" Second Annual Rheumatology Summit for Fellows: Optimizing Therapy While Reducing Risk

1.50 CME
$0 FEE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

"Best of" Second Annual Rheumatology Summit for Fellows: Optimizing Therapy While Reducing Risk


Provider Statement

This continuing medical education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by educational grants from AbbVie Inc., Bristol-Myers Squibb, Celgene Corporation, and Novartis Pharmaceuticals Corporation.

Activity Description

Rheumatology has seen rapid growth in both basic science and clinical understanding in recent years, much of which is inadequately addressed in medical training programs. There has also been an increase in the number of rheumatology fellowship programs to meet the increasing demand. To address gaps in knowledge and training in medical training programs regarding the management of patients with rheumatic disease, Vindico Medical Education held a day-long virtual educational activity for rheumatology fellows, led by an interdisciplinary panel of experts, addressing the treatment of patients with rheumatic disease as well as the management of associated complications and comorbidities. This "Best of" program provides highlighted presentations from that program.

Target Audience

The intended audience for this activity is rheumatology fellows and other health care professionals involved in the treatment of patients with rheumatic diseases.

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Assess patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), or spondyloarthritis (SpA) for disease activity, prognosis, and comorbidities, such as serious and opportunistic infections, cardiovascular disease, mental health disorders, and other complications.
  • Apply the latest treat-to-target guideline approaches for the management of patients with RA, PsA, or SpA.
  • Incorporate best practices for preventing and monitoring complications for patients with rheumatic disease, including risk profiling and vaccinations.


Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic
Cleveland, OH

M. Elaine Husni, MD, MPH
Vice Chair of Rheumatology
Director, Arthritis and Musculoskeletal Center
Cleveland Clinic
Assistant Professor
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Cleveland, OH


Cassandra Calabrese, DO
Rheumatology and Infectious Disease
Cleveland Clinic Foundation
Cleveland, OH

Stanley Cohen
Clinical Professor
Department of Internal Medicine
University of Texas Southwestern Medical School
Co- Director, Division of Rheumatology
Presbyterian Hospital
Co-Medical Director, Metroplex Clinical Research Center
Dallas, TX

Anisha B. Dua, MD, MPH
Associate Professor, Fellowship Program Director
Director of the Vasculitis Center
Northwestern University Feinberg School of Medicine
Chicago, IL


Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP 


Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

This enduring material is approved for 1 year from the date of original release, November 17, 2020, to November 16, 2021.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of the 3 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.


In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.  

Co-Chairs and Faculty report the following relationship(s)

Cassandra Calabrese, DO
Consulting Fee: AbbVie
Speakers Bureau: Regeneron

Leonard H. Calabrese, DO
Consulting Fee: AbbVie, Amgen, Bristol-Myers Squibb, Crescendo, Genentech, Gilead, GlaxoSmithKline, Horizon, Janssen, Kiniksa, Lilly, Pfizer, Sanofi-Regeneron, UCB
Speakers Bureau: AbbVie, Bristol-Myers Squibb, Crescendo, Genentech, Horizon, Sanofi, UCB

Stanley Cohen
Consulting Fee: AbbVie, Amgen, Genentech, Gilead, Lilly, Pfizer
Contracted Research (Paid to Institution): AbbVie, Amgen, Genentech, Gilead, Lilly, Pfizer

Anisha Dua
Consulting Fee: AbbVie, Chemocentryx, GlaxoSmithKline, Novartis
Speakers Bureau: AbbVie

M. Elaine Husni, MD, MPH
Consulting Fee: AbbVie, Janssen, Lilly, Novartis, Pfizer, UCB
Contracted Research: Pfizer

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose. 

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non—FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at cme@vindicoCME.com